Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
June 14, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and...
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
June 11, 2024 16:05 ET
|
Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
WellSpan Health Partners with Jersey College to Establish a Dedicated School of Nursing in South Central Pennsylvania
June 11, 2024 09:41 ET
|
WellSpan Health
York, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- WellSpan Health and Jersey College, an accredited post-secondary institution specializing in nursing education, have received regulatory approval to...
2024 Fitzgerald Prize Laureate Announced at Hôtel Belles Rives
June 07, 2024 20:08 ET
|
Hotel Belles Rives
CAP D’ANTIBES, France, June 07, 2024 (GLOBE NEWSWIRE) -- In a ritualistic launch of summer, a ceremony held this evening at Hôtel Belles Rives on the French Riviera, jury members of the 2024...
White House and DOE Announce National Definition for a Zero Emissions Building to Standardize the Pursuit of Decarbonization Goals
June 06, 2024 11:00 ET
|
Green Building Initiative
GBI applauds the White House and the DOE for the release of the first phase of a National Definition for a Zero Emissions Building for the private sector.
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
June 01, 2024 08:00 ET
|
Kymera Therapeutics, Inc.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement...
Fiverr Teams Up with Interior Design Expert and CEO Bobby Berk As New Brand Ambassador Offering Limited Edition Consultations and Exclusive Content
May 30, 2024 08:00 ET
|
Fiverr International Ltd.
As a new brand ambassador for Fiverr, Bobby Berk will provide individuals and businesses with design consultations to transform their home or office
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
May 23, 2024 17:00 ET
|
Kymera Therapeutics, Inc.
Abstract released today highlights safety, pharmacodynamic and clinical response data with additional data to be presented in a poster session on June 1, 2024 KT-253 Phase 1 study ongoing with...
A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research
May 22, 2024 10:23 ET
|
Trial Equity
Trial Equity and Miller Tanner Associates are partnering to expand clinical trial participation to address the gap in diversity.
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.